Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - reboxetine mesilate, quantity: 5.224 mg (equivalent: reboxetine, qty 4 mg) - tablet, uncoated - excipient ingredients: calcium hydrogen phosphate dihydrate; microcrystalline cellulose; crospovidone; magnesium stearate; silicon dioxide - indications: edronax is indicated for the treatment of major depression and is effective in preventing the relapse of depressive symptoms.

Israel - English - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - reboxetine methan sulfonate - tablets - reboxetine methan sulfonate 4 mg - reboxetine - reboxetine - reboxetine is indicated for the acute treatment of depressive illness/major depression and for maintaining the clinical improvement in patients initially responding to treatment.

New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - reboxetine mesilate 2.612mg equivalent to 2 mg reboxetine free base - tablet - 2 mg - active: reboxetine mesilate 2.612mg equivalent to 2 mg reboxetine free base excipient: calcium hydrogen phosphate dihydrate crospovidone hydrated silica magnesium stearate powdered cellulose - reboxetine is indicated for the treatment of depressive illness and for maintaining the clinical improvement in patients initially responding to treatment. the remission of the acute phase of the depressive illness is associated with an improvement in the patient's quality of life in terms of social adaptation.

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

pfizer sa-nv - reboxetine mesilate 5,22 mg - eq. reboxetine 4 mg - tablet - 4 mg - reboxetine mesilate 5.22 mg - reboxetine

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

imported - reboxetine mesilate - oral tablet - 4mg

New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - reboxetine mesilate 5.224mg equivalent to 4 mg reboxetine free base - tablet - 4 mg - active: reboxetine mesilate 5.224mg equivalent to 4 mg reboxetine free base excipient: calcium hydrogen phosphate dihydrate crospovidone hydrated silica magnesium stearate powdered cellulose

Ireland - English - HPRA (Health Products Regulatory Authority)

pfizer healthcare ireland - reboxetine - tablet - 4 milligram(s) - other antidepressants; reboxetine

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

pfizer ltd - reboxetine mesilate - oral tablet - 4mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

waymade healthcare plc - reboxetine mesilate - oral tablet - 4mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

dowelhurst ltd - reboxetine mesilate - oral tablet - 4mg